Their policies could end up boosting growth, though companies may get a smaller slice
Financial markets have been on a rollercoaster over the past year. There was a sharp drop in March as countries locked down and then a swift upswing followed, led by technology shares. Even unloved companies, particularly banks and energy firms, have rebounded lately, thanks to good news about vaccines.
We close a difficult year with a sense of relief, and the tools to deal with the challenges ahead.
This article makes the case for knowing what’s under the bonnet before investing in innovative new exchange-traded funds (ETFs).
Stock markets shot the lights out in November as news of promising vaccines hit the wires. The realities of distribution have lessened the glow a bit recently, leading investors to start reassessing their approach.
Rather than try to reduce it by austerity, inflation or default, the government should focus on keeping the rate of economic growth above the cost of servicing the debt.
Do changes at The Fed mean low rates forever?
News of a potentially viable vaccine is welcome, yet markets have rocketed back extremely quickly considering it is yet to be approved. With COVID-19 spreading rapidly once again, time is of the essence.
Stimulus should be forthcoming and trade uncertainty relieved, even if Congress remains split
